Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol

Louisa J D van Dijk1,2, Jihan Harki3, Desirée van Noord3,4

  • 1Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. l.vandijk@erasmusmc.nl.

Trials
|August 21, 2019
PubMed

Insights

The CoBaGI trial compares covered stents (CS) to bare-metal stents (BMS) for treating chronic mesenteric ischemia (CMI). This study aims to determine which stent type offers better long-term patency and patient outcomes in atherosclerotic CMI.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Gastroenterology

Background:

  • Chronic mesenteric ischemia (CMI) stems from reduced blood flow to the intestines, primarily due to atherosclerotic narrowing of mesenteric arteries.
  • Revascularization is crucial for managing CMI, preventing severe complications, and improving patient quality of life.
  • Endovascular therapy is now the preferred treatment for CMI, with ongoing research into optimal stent technologies.

Purpose of the Study:

  • To prospectively evaluate and compare the primary stent patency rates of covered stents (CS) versus bare-metal stents (BMS) in patients with atherosclerotic CMI.
  • To assess secondary endpoints including restenosis, symptom recurrence, re-intervention rates, quality of life, and cost-effectiveness.
  • To establish CS as a potentially superior option to BMS for treating CMI.

Main Methods:

  • The CoBaGI trial is a randomized, controlled, blinded, multicenter superiority trial involving 84 patients.
  • Participants are randomized 1:1 to receive either a balloon-expandable BMS or a balloon-expandable CS.
  • The primary endpoint is primary stent patency at 24 months, assessed via CT angiography.

Main Results:

  • The study is designed to provide definitive data on stent patency at 24 months.
  • Secondary analyses will examine patency at 6 and 12 months, alongside clinical outcomes.
  • Quality of life and cost-effectiveness will also be analyzed over the 24-month period.

Conclusions:

  • The CoBaGI trial is the first randomized controlled trial investigating CS versus BMS for CMI caused by atherosclerotic mesenteric stenosis.
  • Results will inform clinical practice regarding the optimal stent choice for CMI treatment.
  • The study will also offer insights into the impact of stenting on patient quality of life and its economic implications.
Abstract

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
241
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
390
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
412
Anatomy of the Gastrointestinal System01:26

Anatomy of the Gastrointestinal System

The human digestive system is an intricate and essential network for nutrient absorption and waste elimination. It encompasses the gastrointestinal (GI) tract and several accessory organs.
Here's a detailed walkthrough of this complex system:
2.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K